Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Zepbound (tirzepatide for weight management) carries a warning about suicidal thoughts and behaviors
December 2025: Emcure Pharmaceuticals launched Poviztra, a semaglutide-based weight-loss therapy, at USD 106 (INR 8,790) per month, becoming the first Indian company to commercialize Novo Nordisks molecule for obesity
Disclosure Notice The information contained in this release is as of April 14, 2025
The Weekly Protocol Once cleared for treatment, your regimen is designed to be simple, consistent, and minimally invasive
While in-person doctor visits or pharmacy pickups arent required, you still need to obtain a physician-approved prescription to start the program
US$ 28.78
US$ 29.94
US$ 28.71
US$ 20.26
US$ 22.74
US$ 27.20
US$ 22.87
![tirzepatide court UPDATE [March 7, 2025]: OFA takes case to appeals as legal battle evolves FDA's tirzepatide decision creates uncertainty court ruling on tirzepatide case –](https://static.wixstatic.com/media/60489a_95b142b425f4416b99f8a052fde88da7~mv2.jpg/v1/fill/w_980,h_551,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/60489a_95b142b425f4416b99f8a052fde88da7~mv2.jpg)
